Skip to main content
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;95(3):233–237. doi: 10.1111/j.1349-7006.2004.tb02208.x

Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer

Akiko Ioka 1,, Hideaki Tsukuma 1, Wakiko Ajiki 1, Akira Oshima 1
PMCID: PMC11159653  PMID: 15016322

Abstract

The survival of ovarian cancer patients has been reported to be superior at hospitals with a high volume of operations. A population‐based study was carried out to assess whether this is true in Japan, where the incidence rate is relatively low as compared with other developed countries. The Osaka Cancer Registry's data were used to investigate associations between hospital procedure volume and survival of ovarian cancer patients. Hospitals were ranked according to the number of operations for ovarian cancer performed per year (high/medium/low/very low). Survival analysis was restricted to the reported 2450 cases who lived in Osaka Prefecture (except for Osaka City) diagnosed in 1975–1995, or those who resided in Osaka City in 1993–1995, since active follow‐up data on vital status 5 years after the diagnosis were available. The relative 5‐year survival for all ovarian cancer cases was 38.8%, and the survival was higher with greater hospital volume (22.3%/34.2%/46.2%/55.0%). After adjustment for age, histologic type and cancer stage by the Cox regression model, patients receiving care in very‐low‐volume hospitals were seen to have a 60% higher risk of death than patients receiving care in high‐volume hospitals (P<0.01). Although some limitations existed in this study, the results indicated that further centralization of operative treatment in high‐volume hospitals might improve survival of ovarian cancer patients in Japan.

This work was supported in part by a Grant‐in‐Aid for Cancer Research (14–2) from the Ministry of Health, Labour and Welfare of Japan.

References

  • 1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents vol. VIII. In: IARC Scientific Publ. no. 155. Lyon , France : International Agency for Research on Cancer; 2002. [Google Scholar]
  • 2. Ioka A, Tsukuma H, Ajiki W, Oshima A. Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 2003; 94: 292–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cy‐toreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983; 61: 413–20. [PubMed] [Google Scholar]
  • 4. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 101–4. [PubMed] [Google Scholar]
  • 5. Laurvick CL, Semmens JB, Leung YC, Holman CD. Ovarian cancer in Western Australia (1982–1998): trends in surgical intervention and relative survival. Gynecol Oncol 2003; 88: 141–8. [DOI] [PubMed] [Google Scholar]
  • 6. Oshima A, Kitagawa T, Ajiki W, Tsukuma H, Takenaka S, Iura A. Survival of testicular cancer patients in Osaka, Japan. Jpn J Clin Oncol 2001; 31: 438–43. [DOI] [PubMed] [Google Scholar]
  • 7. Williams SD. Ovarian germ cell tumors: an update. Semin Oncol 1998; 25: 407–13. [PubMed] [Google Scholar]
  • 8. Gershenson DM. Update on malignant ovarian germ cell tumors. Cancer 1993; 71: 1581–90. [DOI] [PubMed] [Google Scholar]
  • 9. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747–51. [DOI] [PubMed] [Google Scholar]
  • 10. Hillner BE. Is cancer care best at high‐volume providers? Curr Oncol Rep 2001; 3: 404–9. [DOI] [PubMed] [Google Scholar]
  • 11. Kumpulainen S, Grenman S, Kyyronen P, Pukkala E, Sankila R. Evidence of benefit from centralized treatment of ovarian cancer: a nationwide population‐based survival analysis in Finland. Int J Cancer 2002; 102: 541–4. [DOI] [PubMed] [Google Scholar]
  • 12. Estev J, Benhamou E, Raymond L. Statistical methods in cancer research vol. IV: Descriptive epidemiology. In: IARC Scientific Publ. no. 128. Lyon , France : International Agency for Research on Cancer; 1994. p. 231–45. [PubMed] [Google Scholar]
  • 13. The Research Group for Population‐based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1997: estimates based on data from 12 population‐based cancer registries. Jpn J Clin Oncol 2002; 32: 318–22. [DOI] [PubMed] [Google Scholar]
  • 14. Tamakoshi K, Kondo T, Yatsuya H, Hori Y, Kikkawa F, Toyoshima H. Trends in the mortality (1950–1997) and incidence (1975–1993) of malignant ovarian neoplasm among Japanese women: analyses by age, time, and birth cohort. Gynecol Oncol 2001; 83: 64–71. [DOI] [PubMed] [Google Scholar]
  • 15. Richardson GS, Scully RE, Nikrui N, Nelson JH Jr. Common epithelial cancer of the ovary. N Engl J Med 1985; 312: 415–24. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES